Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
|---|---|---|---|---|
| HCC1419 | Alvocidib | 0.000316227766017 | 1.2391 | -0.00328 |
| HCC1419 | Alvocidib | 0.000316227766017 | 1.0157 | -0.00640 |
| HCC1419 | Alvocidib | 0.000316227766017 | 0.9570 | -0.00053 |
| HCC1419 | Alvocidib | 0.001 | 0.9401 | -0.00975 |
| HCC1419 | Alvocidib | 0.001 | 0.9470 | 0.00071 |
| HCC1419 | Alvocidib | 0.001 | 1.0475 | -0.00410 |
| HCC1419 | Alvocidib | 0.00316227766017 | 0.7552 | -0.00148 |
| HCC1419 | Alvocidib | 0.00316227766017 | 1.0282 | -0.00825 |
| HCC1419 | Alvocidib | 0.00316227766017 | 0.9522 | 0.00126 |
| HCC1419 | Alvocidib | 0.01 | 0.9843 | -0.01083 |
| HCC1419 | Alvocidib | 0.01 | 0.9485 | 0.01266 |
| HCC1419 | Alvocidib | 0.01 | 0.8489 | -0.00479 |
| HCC1419 | Alvocidib | 0.0316227766017 | 0.8629 | 0.00211 |
| HCC1419 | Alvocidib | 0.0316227766017 | 0.9775 | 0.00329 |
| HCC1419 | Alvocidib | 0.0316227766017 | 0.8907 | -0.00389 |
| HCC1419 | Alvocidib | 0.1 | 0.4575 | 0.00719 |
| HCC1419 | Alvocidib | 0.1 | 0.7002 | 0.00678 |
| HCC1419 | Alvocidib | 0.1 | 0.6658 | 0.00172 |
| HCC1419 | Alvocidib | 0.316227766017 | 0.3363 | 0.00725 |
| HCC1419 | Alvocidib | 0.316227766017 | 0.3846 | 0.01734 |
| HCC1419 | Alvocidib | 0.316227766017 | 0.4100 | 0.02064 |
| HCC1419 | Alvocidib | 1.0 | -0.2663 | 0.12568 |
| HCC1419 | Alvocidib | 1.0 | -0.2582 | 0.12836 |
| HCC1419 | Alvocidib | 1.0 | -0.2626 | 0.08745 |
| HCC1419 | GSK2334470 | 0.001 | 1.1346 | -0.00514 |